Hunt A, Harrington D, Robinson S
This guide examines each cost component, insurance coverage options, prescription requirements, and important considerations for patients exploring MIC B12 injection treatments under medical supervision
Estimation of vitamin C intake requirements based on body weight: implications for obesity
Conditions include alcoholic liver disease, viral hepatitis, cirrhosis, and primary or metastatic liver cancer Renal dysfunction : Impaired kidney function reduces B12 elimination, causing accumulation even with normal intake Haematological conditions : Myeloproliferative neoplasms, chronic myeloid leukaemia, polycythaemia vera, and hypereosinophilic syndrome increase transcobalamin production, elevating total serum B12 Laboratory interference : Macro-B12 (immunoglobulin-bound B12) and assay interference can cause spuriously elevated results without true excess In clinical practice, unexplained hypercobalaminaemia should prompt investigation for underlying disease, particularly in patients without obvious supplementation history
Furthermore, our expert team does NOT believe the quantity of methionine in our current B12/MIC formulation is enough to activate mTOR in any clinically meaningful way (our expert pharmacists agree!)
Patients with peripheral neuropathy often see meaningful improvement with consistent therapy
